Back To Schedule
Thursday, July 1 • 11:30am - 12:30pm
#429 SL: The Journey to a Modernization of Analytics

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-656-L04-P; CME 1.00; IACET 1.00; RN 1.00

This forum will present on the statistical analytics assessment framework based on risk as to the factors that contribute to confidence or trust for various statistical software, tools, and applications. A panel of experts will provide their experiences.

Learning Objectives

Describe best practices to achieve a modernization of analytics within biostatistics and data science.


Peter Mesenbrink, PhD


Changing How We Use Modern Analytics in Clinical Drug Development
Peter Mesenbrink, PhD

Industry Update
Daniel Woodie, MS

Industry Update
Andy Nicholls, MSc

Industry Update
Min Lee

avatar for Peter Mesenbrink

Peter Mesenbrink

Executive Director of Biostatistics, Novartis Pharmaceuticals Corporation, United States
Peter Mesenbrink, PhD is an Executive Director of Biostatistics at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. Peter received his BS in Mathematics from UVM in 1989 and a PhD in Statistics from NCSU in 1995. He joined Novartis in 1995 and is currently Therapeutic... Read More →

Daniel Woodie

Senior Scientist, Statistical Programming, Merck & Co., Inc., United States

Andy Nicholls

Senior Director, Head of Statistical Data Sciences, GlaxoSmithKline, United Kingdom
Andy Nicholls is Head of Statistical Data Sciences at GSK. Andy is responsible for building Data Science capability within GSK Biostatistics and delivering Data Science solutions across R&D. Within the wider pharmaceutical industry, Andy is the lead for the R Validation Hub, a collaboration... Read More →

Min Lee

Director of Biostatistical Programming, Amgen, United States

Thursday July 1, 2021 11:30am - 12:30pm EDT
TBD Virtual Event Horsham, PA 19044
  11: Statistics, Forum